Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diagnostic approach to IBD.

S Vermeire1, M Peeters, P Rutgeerts

  • 1Department of Gastroenterology, University Hospital Gasthuisberg, Leuven, Belgium.

Hepato-Gastroenterology
|February 26, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Protein-level profiling of TIGIT axis components in human PDAC reveals immune-suppressive expression patterns.

Cancer immunology, immunotherapy : CII·2026
Same author

Label-free electrochemical levodopa detection via dummy imprinted polymers for advanced disease monitoring.

Analytica chimica acta·2026
Same author

Cardiovascular toxicities in cancer patients treated with immune checkpoint inhibitors: multicenter study using natural language processing on Belgian hospital data.

ESMO real world data and digital oncology·2026
Same author

Acute hepatitis E-related Guillain-Barré syndrome.

Acta gastro-enterologica Belgica·2025
Same author

Management of high-grade neuroendocrine neoplasms: impact of functional imaging.

Endocrine-related cancer·2025
Same author

Fluoropyrimidine type, patient age, tumour sidedness and mutation status as determinants of benefit in patients with metastatic colorectal cancer treated with EGFR monoclonal antibodies: individual patient data pooled analysis of randomised trials from the ARCAD database.

British journal of cancer·2024
Same journal

Palliative Surgery for Gastric Cancer with Gastric Outlet Obstruction or Anemia due to Tumor Bleeding.

Hepato-gastroenterology·2016
Same journal

A Novel "Artery First" Approach Allowing Safe Resection in Laparoscopic Pancreaticoduodenectomy: The Uncinate Process First Approach.

Hepato-gastroenterology·2016
Same journal

A Phase I Study of S-1 and Gemcitabine with Concurrent Radiotherapy in Patients with Non-Metastatic Advanced Pancreatic Cancer.

Hepato-gastroenterology·2016
Same journal

A Novel Approach for Endoscopic Papillary Balloon Dilation with the Guidewire Left in the Pancreatic Duct to Ensure Pancreatic Stenting.

Hepato-gastroenterology·2016
Same journal

Which Factors are Predictive for Mortality among Hospitalized Patients with Cirrhosis?

Hepato-gastroenterology·2016
Same journal

Hydrodynamics Analysis and CFD Simulation of Portal Venous System by TIPS and LS.

Hepato-gastroenterology·2016
See all related articles

Diagnosing inflammatory bowel disease (IBD) can be challenging due to varied symptoms. New serological markers like pANCA and ASCA improve diagnostic accuracy and may help identify patient subgroups for targeted therapies.

Area of Science:

  • Gastroenterology
  • Immunology
  • Genetics

Background:

  • Inflammatory bowel disease (IBD) encompasses Crohn's disease and ulcerative colitis, characterized by unknown etiology and heterogeneous presentations.
  • Delayed diagnosis in IBD can significantly impact patient outcomes.
  • Current diagnostic methods rely on clinical, radiographic, endoscopic, and laboratory data.

Purpose of the Study:

  • To evaluate the role of serological markers in improving the accuracy of initial IBD diagnosis.
  • To explore the potential of identifying patient subgroups using genetic, immunologic, and clinical markers for precise diagnosis and drug trial stratification.

Main Methods:

  • Review of current diagnostic approaches for IBD.
  • Analysis of the utility of serological markers, specifically perinuclear anti-neutrophil cytoplasmic antibodies (pANCA) and anti-Saccharomyces cerevisiae antibodies (ASCA).

Related Experiment Videos

Main Results:

  • Serological markers such as pANCA and ASCA can enhance the diagnostic accuracy of inflammatory bowel disease at the initial presentation.
  • These markers show potential in differentiating between subtypes of IBD, aiding in subgroup identification.

Conclusions:

  • The integration of serological markers like pANCA and ASCA represents a significant advancement in the initial diagnosis of IBD.
  • These markers may play a crucial role in defining disease subgroups, paving the way for personalized medicine and improved therapeutic strategies in IBD management.